தொகுதி 2, பிரச்சினை 3 (2005)
கட்டுரையை பரிசீலி
New advances in interleukin 1 blockade for the treatment of rheumatoid arthritis
Joseph A Markenson
கட்டுரையை பரிசீலி
Interferon alpha therapy and Type 1 diabetes in patients with hepatitis C: pathophysiologic insights
Ayse Aytaman, Gul Bahtiyar and Samy I McFarlane
கட்டுரையை பரிசீலி
Therapy of chronic renal insufficiency – from renal physiology to cardiovascular outcomes
Rainer U Pliquett
ஆய்வுக் கட்டுரை
PTH-related protein and Type 1 parathyroid hormone receptor mRNA expression in rat ventricular myocardial hypertrophy
Antony Halapas, Peter Lembessis, Antigone Sourla, Costas Pantos, Dennis V Cokkinos and Michael Koutsilieris
ஆய்வுக் கட்டுரை
Preparation of a polymeric reservoir naltrexone delivery device: Effect of PEG content of the PLA membrane on drug release
Rassoul Dinarvand, Shadi H Moghadam, Pantea Sayar, Mahsa Alaee and Fatemeh Atyabi
ஆய்வுக் கட்டுரை
Does the addition of lamotrigine to risperidone improve psychotic symptoms and cognitive impairements in chronic schizophrenia?
Shahin Akhondzadeh, K Mackinejad, SA Ahmadi-Abhari and ZM Alem
ஆய்வுக் கட்டுரை
Influence of serum epidermal growth factor on mechanical ventilation and survival in patients with acute respiratory distress syndrome
Pooneh Salari, Mojtaba Mojtahedzadeh and Mohammad Abdollahi
குறுகிய அறிக்கை
Chronic tendon pain: no tendinitis, but high levels of glutamate and a vasculoneural ingrowth – implications for a new treatment?
Hakan Alfredson and Lars Ohberg
கட்டுரையை பரிசீலி
Are the benefits of NSAIDs to decrease the risk of Alzheimer\'s disease a MIRAGE?
John B Standridge
மருந்து மதிப்பீடு
Management of community-acquired lower respiratory tract infections: gemifloxacin; a new economic paradigm
Gary Patou, Glenn Tillotson and Joseph Blondeau
